ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
6.05
+0.37 (6.51%)
At close: Sep 4, 2026, 4:00 PM EDT
5.93
-0.12 (-1.98%)
After-hours: Sep 4, 2026, 4:34 PM EDT
ENDRA Life Sciences Earnings Call Transcripts
Fiscal Year 2024
-
Q2 2024 saw a $7.3M capital raise, 26% cut in operating expenses, and a strategic shift toward primary care and endocrinology for the TAEUS liver device. FDA submission is targeted for mid-2025, with a strengthened management team and expanded patent portfolio.